Cambridge Capital Group

Type

Angel Group/Syndicate

Status

Active

Total investments

45

Average round size

3M

Portfolio companies

30

Rounds per year

1.88

Lead investments

1

Follow on index

0.33

Exits

7

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareArtificial IntelligenceHealth CareMedicalDeveloper PlatformWeb DesignHardwareWeb Development

Summary

In 2000 was created Cambridge Capital Group, which is appeared as VC. The main office of represented VC is situated in the Cambridge. The fund was located in Europe if to be more exact in United Kingdom.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Cambridge Capital Group, startups are often financed by Cambridge Angels group, University of Cambridge Enterprise, Octopus Ventures. The meaningful sponsors for the fund in investment in the same round are 3i Group, University of Cambridge Enterprise, Imperial Innovations. In the next rounds fund is usually obtained by Cambridge Angels group, 3i Group, Nesta Ventures.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Advanced Materials. Among the various public portfolio startups of the fund, we may underline Featurespace, Light Blue Optics, Nujira For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 3 of the founder, the chance for it to get the investment is meager.

The fund was created by Struan McDougall. The overall number of key employees were 3.

Comparing to the other companies, this Cambridge Capital Group performs on 22 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 16 percentage points less often commits exit comparing to other organizations. The high activity for fund was in 2013. The top amount of exits for fund were in 2019. The fund is constantly included in less than 2 investment rounds annually.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
45
Lead investments
1
Exits
7
Rounds per year
1.88
Follow on index
0.33
Investments by industry
  • Software (13)
  • Biotechnology (12)
  • Artificial Intelligence (7)
  • Medical (7)
  • Hardware (6)
  • Show 67 more
Investments by region
  • United Kingdom (42)
  • United States (3)
Peak activity year
2013

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
524K
Group Appearance index
0.96
Avg. company exit year
10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Cambridge GaN Devices 18 Feb 2021 Semiconductor Early Stage Venture 9M Cambridgeshire, Cambridge, United Kingdom
Next Academy 06 Sep 2015 Education, Sports, Franchise Seed 1M Rio de Janeiro, Rio De Janeiro, Brazil
Oval Medical Technologies Ltd. 01 Mar 2010 Health Care, Medical Seed 674K United States, Massachusetts, Cambridge

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.